Headlands Technologies’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,082
| Closed | -$95.7K | – | 1421 |
|
|
2024
Q4 | $95.7K | Sell |
5,082
-3,293
| -39% | -$62K | 0.01% | 675 |
|
|
2024
Q3 | $126K | Buy |
+8,375
| New | +$126K | 0.01% | 625 |
|
|
2024
Q2 | – | Sell |
-463
| Closed | -$13.5K | – | 1498 |
|
|
2024
Q1 | $13.5K | Buy |
+463
| New | +$13.5K | ﹤0.01% | 987 |
|
|
2023
Q4 | – | Sell |
-1,831
| Closed | -$56.2K | – | 1216 |
|
|
2023
Q3 | $56.2K | Sell |
1,831
-1,424
| -44% | -$43.7K | 0.03% | 419 |
|
|
2023
Q2 | $130K | Buy |
+3,255
| New | +$130K | 0.04% | 347 |
|